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Abstract
The purpose of the present study was to investigate the efficacy of perioperative oral managements (POMs) on perioperative
nutritional conditions in patients undergoing surgery with general anesthesia. Medical records were retrospectively reviewed and the
effects of POMs were investigated based on a large number of cases using a multicenter analysis. The profile of serum albumin levels
was assessed and compared between patients with and without POMs using the multivariate analysis. Seventeen Eleven thousand
and one hundred sixty patients (4,873 males and 6,287 females) were reviewed. Of these, 2710 patients (24.3%) had undergone
POMs. The results of a multivariate analysis revealed the significant positive effect of POMs on perioperative serum albumin level
(change between at admission and discharge, (Estimate: 0.022, standard error: 0.012, P< .0001). Patient gender, age, surgical site,
performance status, the American Society of Anesthesiologists (ASA) physical status classification, operation time, amount of blood
loss, and serum albumin level at admission were also significant predictors. Adjusted multivariate analysis of the effects of POMs on
perioperative change of serum albumin level in all subjects reveled the significance of POMs intervention (estimate: 0.022, standard
error: 0.012, P< .0001). These results suggest that POMs exerts significant positive effects on perioperative serum albumin levels in
patients underwent surgery under general anesthesia.
Abbreviations: ASA = American Society of Anesthesiologists, POMs = perioperative oral managements.
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Pre-operative oral care has been reported as an effective and easy
method to prevent post-operative pneumonia in patients
undergoing esophagectomy.[1,2] The Surgeon General’s report
on oral health in America showed that oral functional
management prevented general complications during the peri-
operative period.[3]
In Japan, perioperative oral managements (POMs) was
introduced by the national health insurance system in 2012
and patients scheduled for surgery for cancer, cardiovascular
diseases, and organ transplantation receive dental and oral
functional management during the perioperative period. POMs
may have an impact on the prevention of dental-related local and
systemic infections in patients compromised by intensive surgery.
The positive effects of POMs on the prevention of postoperative
pneumonia, which has been attributed to the aspiration of oral/
oropharyngeal pathogens, have been reported in some cancer
patients.[1,2,4–6]
Serum albumin has a number of roles, such as in cell growth
stabilization, DNA replication, the maintenance of sex hormone
homeostasis, and modulation of systemic inflammation.[7]
Albumin has been reported to be involved in inflammatory/
stress reactions.[8] According to a study on colorectal cancer
patients, hypoalbuminemia was reported to reflect the conditions
of malnutrition and immunosuppression, and increase the risk of
increased disease severity, tumor progression, and a poor
prognosis.[8] Inflammatory cytokines have been reported to
trigger apoptosis and decrease the production of albumin mRNA
by the liver, resulting in reductions in its synthesis and increases in
albumin catabolism, and vascular permeability.[9,10] An early
decrease in postoperative serum albumin was identified as an
independent risk factor associated with severe postoperative
complications and a poor prognosis.[11,12] Although early
decreases in postoperative serum albumin levels are important
for predicting the prognosis of patients, there is currently no
information available on patients who received POMs. It has also
been reported as a reliable systemic marker of malnutrition.[13]
Malnutrition and inflammatory responses strongly correlate with
severe postoperative complications.[14] Increased oral bacteria,
dental infections, oral mucositis, masticatory disorders due to the
teeth loss result in the decline of the oral function.[15] As a result,
the decline of oral function affects on the nutrition condition in
cancer patients. Although oral and dental conditions play
important roles in nutrition, the effects of POMs on perioperative
serum albumin levels have not yet been investigated except for
1 recent report.[15] In this report, perioperative POMs interven-
tion might have positive effects on the postoperative prognostic
nutrition index (PNI), which was calculated using serum albumin
and the peripheral lymphocyte count, in the patients with
digestive systems or urinary cancer.[15,16] Therefore, the purpose
of the present study was to investigate the efficacy of POMs on
perioperative serum albumin levels in patients treated surgically
under general anesthesia based on a large number of cases using a
multicenter retrospective analysis.
2. Patients and methods
The present study was conducted by the Japanese Stomatological
Society. The study protocol was approved by the Committee on
Medical Research of Shinshu University (#3788). We published
our research plan with a guaranteed opt-out opportunity on the
homepage of each hospital.
A total of 19,646 patients who were scheduled for surgery
under general anesthesia between April 2016 andMarch 2017 at
16 university hospitals were enrolled in the present study. The
medical records of these patients were retrospectively reviewed.
The objective variable was an increase or decrease of periopera-
tive serum albumin level (change between at admission and at
discharge). Since this was a retrospective observational study and
the surgical invasion was different, the serum albumin levels at
discharge was investigated at the time from which the general
condition became calm and home treatment was possible.
Predictor variables were defined as patient factors (age, sex,
smoking habits, diabetes mellitus, severe heart disease, severe
pulmonary disease, Eastern Cooperative Oncology Group
Performance Status,[17] treatment factors (risk of general
anesthesia, surgical site, operation time, days of hospital stay
after operation, and blood loss), and the presence and absence of
POMs. Severe heart disease was defined as ≥ grade 3 of the New
York Heart Association Classification.[18] Severe pulmonary
disease was defined as <60% of % vital capacity or <50% of %
Forced Expiratory Volume in One Second. The risk of general
anesthesia was evaluated with the American Society of
Anesthesiologists (ASA) physical status classification.[19] Surgical
sites were divided into 11 groups: ophthalmic, oral and
maxillofacial, thorax, musculoskeletal, limbs, and trunk, oto-
rhinolaryngologic, cardiovascular, neuro and cranium, genital,
urinary tract and adrenal, skin and subcutaneous tissue, and
abdomen. Operation times were classified by every 3hours and
blood loss by every 300ml.
POMs was generally initiated from the time the decision for
hospitalization was made. POMs included oral health instruc-
tions, the removal of dental calculus (scaling), professional
mechanical tooth cleaning, removal of the tongue coating with a
toothbrush, cleaning dentures, extraction of teeth with severe
periodontitis showing pain, pus discharge, mobility, or marked
alveolar bone loss by anX-ray examination. Basically, removal of
the oral infected lesion was completed preoperatively, and oral
care before and after surgery was continuously intervened by
dental hygienists.
The effects of POMs on the perioperative serum albumin
profile was statistically investigated with Student t-test, Pearson
correlation test, Steel-Dwass test, Spearman rank correlation,
analysis of variance in univariate analysis. A multiple regression
analysis was performed for multivariate analysis. Statistical
analyses were performed using JMP ver.13 (SAS Institute Inc.,
North Carolina). P-values<.05 were considered to be significant.
3. Results
Among 19,646 patients, 8,486 were excluded because of the lack
of important data (serum albumin level at discharge) or any
abnormal values such as outlier; therefore, 11,160 (4,873 males
and 6,287 females) were ultimately examined in the present study
(Fig. 1). Patient characteristics are summarized in Table 1. Mean
age was 57.8±20.8years. According to Eastern Cooperative
Oncology Group Performance Status, score 0 was present in
6,169 patients (55.3%), 1 in 2,553 (22.9%), 2 in 1,054 (9.4%), 3
in 493 (4.4%), and 4 in 266 (2.4%). Regarding the ASA physical
status classification,[19] class 2 was noted in 6,395 patients
(57.3%), 1 in 2,182 (19.6%), 3 in 1,877 (16.8%), 4 in 199
(1.8%), 5 in 7 (0.06%), and 6 in 2 (0.02%).Mean serum albumin
levels at admission and discharge were 4.02±0.58 and 3.51±
0.55g/dl, respectively. A total of 2,710 patients (24.3%) received
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POMs. Median value of hospital days after the operation was 12
days (interquartile range: 8 – 22days).
The results of univariate analyses were also summarized in
Table 1. Change of serum albumin level significantly correlated
with gender, age, presence of diabetes mellitus, smoking habit,
surgical site, preoperative serum albumin level, operation time,
blood loss, and days of hospitalization after the surgery. Decrease
of serum albumin level was higher in those with female, older age,
stop or never smoker, diabetes mellitus, higher preoperative
albumin level, longer operation time, higher amount of blood
loss, and longer hospital days. Performance status, ASA
classification, and intervention of POMs showed no significant
correlation with change of serum albumin level.
The results of a multivariate analysis of the effects of POMs on
perioperative serum albumin levels in all subjects were summa-
rized in Table 2. The results obtained revealed a positive impact
with the intervention of POMs (estimate: 0.019, 95% confidence
interval: 0.033–0.026, P< .05). A negative correlation was noted
with other variables (gender, age, performance status, ASA
classification, and preoperative serum albumin levels). The effects
of POMs on perioperative serum albumin levels differed
according to the surgical site. The effects of POMs on
perioperative serum albumin levels investigated with adjusted
multivariate analysis were summarized in Table 3. The
intervention of POMs was a significant positive effector on
perioperative serum albumin levels (estimate: 0.022, 95%
confidence interval: .033–0.033, standard error: 0.012,
P< .0001).
4. Discussion
To the best of our knowledge, this is the first study to demonstrate
the positive effects of POMs on perioperative serum albumin
levels in patients treated surgically under general anesthesia. In
2012, POMs was included in the national health insurance
system in Japan and has since been widely performed on patients
scheduled for cancer treatments, organ transplantation, cardio-
vascular surgery, and orthopedic implant surgery. Since
professional oral care decreased the number of bacteria in the
oropharynx, resulting in the prevention of aspiration pneumo-
nia,[20] the efficacy of POMs at reducing the prevalence of
postoperative pneumonia was demonstrated in Japanese patients
with esophageal and lung cancers.[1,2,4,6,21] In a literature review
on the effects of POMs in Japanese cancer patients,[2,4–6,21–30]
various effects of POMs were reported, including reductions in
the number of bacteria and bacterial species detected with an
endotracheal bacteriological examination,[22] shorter postopera-
tive hospitalization and fasting periods,[23] and reductions in the
prevalence of surgical site infections (Table 4).[30] In recent
retrospective study based on large number of Japanese cancer
patients, the pre-treatment and completion of POMs were
reported to reduce the risk of oral complications significantly.[31]
Figure 1. Flow-chart of the investigation. POMs = perioperative oral managements.
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Table 1
The characteristics of patients and results of univariate analysis.
Variables
No. of patients, Median,
or Mean±SD
Change of (postoperation - preoperation)
serum albumin level (Mean±SE mg/dL)
or Correlation coefficient Result of univariate analysis
Gender P< .05 (Student t-test)
Male 4873  0.422±0.009
Female 6287  0.525±0.010
Age P< .01 (Pearson correlation test)
Mean±SD 57.8±20.8 r= 0.103
Diabetes mellitus P< .01 (Student t-test)
No 9562  0.458±0.007
Yes 1698  0.520±0.018
Smoking P< .01 (Steel-Dwass test)
Never 7315  0.493±0.631
Stop smoking 2712  0.523±0.628
Continuing 1113  0.164±1.196
Performance status NS (Spearman rank correlation)
score 0 6169 0.483±0.656
score 1 2553  0.523±0.561
score 2 1054  0.525±0.641
score 3 493  0.434±0.623
score 4 266  0.540±0.745
Unknown 625
Sever heart disease NS (student t-test)
No (NYHA<3) 10,104  0.500±0.006





No 6981  0.440±0.010
Yes 286  0.406±0.048
Unknown 3893
ASA physical status classification NS (p=0.057) (Spearmans rank correlation)
class 1 2182  0.454±0.599
class 2 6395  0.523±0.627
class 3 1877  0.472±0.676
class 4 199  0.403±0.742
class 5 7  0.757±0.707
class 6 2  0.000±1.556
Unknown 498
Surgical site P< .01 (ANOVA)
Ophthalmic 203 0.019±0.050
Oral and Maxillofacial 576  0.336±0.029
Thorax 1429  0.541±0.019
Musculoskeletal, limbs, and trunk 1273  0.439±0.020
Otorhinolaryngologic 584  0.406±0.029
Cardiovascular 1713  0.407±0.017
Neuro and cranium 680  0.498±0.027
Urinary tract and adrenal 693  0.519±0.027
Abdomen 2381  0.459±0.015
Skin or subcutaneous tissue 288  0.261±0.042
Genital 1332  0.658±0.019
Others 8
Preoperative serum albumin P< .01 (Pearson correlation test)
Mean±SD (g/dl) 4.02±0.58 r= 0.548
Operation time P< .01 (Spearman rank correlation)
Median (IQR) (min) 258 (182–363) r=0.085
Blood loss P< .01 (Spearman rank correlation)
Median (IQR) (mL) 100 (10–415) r=0.603
Intervention of POMs NS (student t-test)
No 8450  0.468±0.008
Yes 2710  0.462±0.014
Days of hospital stay after operation p<0.01 (Spearman rank correlation)
Median (IQR) (days) 12 (8–22) r=0.056
Difference of hospital P< .01 (ANOVA)
(continued )





No. of patients, Median,
or Mean±SD
Change of (postoperation - preoperation)
serum albumin level (Mean±SE mg/dL)
or Correlation coefficient Result of univariate analysis
A 571  0.571±0.029
B 3911  0.515±0.011
C 25  0.348±0.139
D 923  0.598±0.023
E 883  0.366±0.023
F 1357  0.512±0.019
G 762  0.523±0.025
H 611  0.312±0.028
I 532  0.430±0.030
J 311  0.656±0.039
K 122  0.139±0.063
L 22  0.255±0.148
M 474 0.217±0.032
N 656  0.535±0.027
ANOVA = analysis of variance, NS = not significant.
No (%vital capacity ≥60% or FEV1.0% ≥50%) NS = not significant.
Yes (%vital capacity <60% or FEV1.0%<50%).
∗
severe pulmonary disease .
Table 2
A multivariate analysis of the effects of POMs on perioperative change of serum albumin level in all subjects.
Variables Estimate 95% CI P value (Prob>jtj) Variance Inflation Factor
Gender (female/male) 0.040 0.027 – 0.061 < .01 1.27
Age (years) 0.006 0.005 – 0.136 < .01 1.20
Diabetes mellitus (presence/absence) 0.012 0.003 – 0.015 .114 1.07
Smoking .600
Continuing/stop smoking 0.005 0.026 – 0.004 .765 2.42
Never/stop smoking 0.009 0.030 – 0.013 .380 2.72
Performance status 0.022 0.009 – 0.037 <.01 1.52
Severe pulmonary disease (yes/no) 0.014 0.013 – 0.010 .316 1.25
Severe heart disease (yes/no) 0.022 0.011 – 0.012 .190 1.04
ASA physical status classification 0.072 0.050 – 0.077 <.0001 1.65
Surgical site (vs Abdomen) < 0.01
Ophthalmic 0.102 0.394 – 0.067 .496 116.40
Oral and Maxillofacial 0.037 0.134 – 0.029 .464 18.38
Thorax 0.206 0.115 – 0.191 < .01 22.31
Musculoskeletal, limbs, and trunk 0.053 0.039 – 0.046 .260 20.14
Otorhinolaryngologic 0.027 0.129 – 0.020 .612 18.41
Cardiovascular 0.113 0.026 – 0.113 <.05 24.11
Neuro and cranium 0.019 0.075 – 0.016 .688 19.40
Genital 0.213 0.122 – 0.190 <.01 20.68
Urinary tract and adrenal 0.145 0.047 – 0.112 <.01 17.82
Skin or subcutaneous tissue 0.046 0.064 – 0.033 .410 19.39
Others 0.813 1.688 – 0.534 .069 1034.65
Preoperative serum albumin (g/dL) 0.730 0.710 – 0.710 <.01 1.18
Operation time (minutes) 0.000 0.000 – 0.039 <.01 1.20
Blood loss (mL) 0.000 0.000 – 0.059 <.01 1.34
Intervention of POMs (presence/absence) 0.019 0.033 – 0.026 < .05 1.28
Days of hospital stay after operation (days) 0.000 0.001 – 0.016 .114 1.22
Difference of hospital (vs M & N) <.01
A 0.093 0.044 – 0.060 <.01 3.13
B 0.022 0.133 – 0.011 .702 9.54
C 0.046 0.221 – 0.022 .610 22.00
D 0.006 0.036 – 0.005 .770 3.24
E 0.094 0.138 – 0.069 < .01 3.24
F 0.043 0.081 – 0.037 <.05 3.26
G 0.112 0.067 – 0.081 <.01 3.17
H 0.044 0.003 – 0.029 .067 3.10
I 0.036 0.012 – 0.024 .139 3.15
J 0.156 0.091 – 0.091 <.01 4.57
K 0.128 0.240 – 0.063 <.05 9.71
L 0.068 0.295 – 0.032 .555 35.91
95% CI = 95% confidence interval, POMs = perioperative oral managements.
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However, since difficulties are associated with conducting a
prospective randomized controlled trial to investigate the efficacy
of POMs in cancer patients, its efficacy based on a high evidence
level has not yet been demonstrated.[32]
In a recent report investigated the correlation between POMs
and PNI score in cancer patients, patients who received POMs
showed significantly higher PNI scores from the early postoper-
ative period, compared those not receiving POMs.[15] Addition-
ally, among patients who could resume oral intake within
postoperative 3 days, those who received POMs intervention
showed significantly higher PNI scores from the early postoper-
ative period, compared to patients without POMs.[15] Although
these results might suggest the favorable effects of POMs on
perioperative nutrition status in cancer patients, there was
limitations such as a retrospective study based on relatively small
number of cases at single institute. Therefore, in the present study,
to obtain new evidence to support POMs for patients treated
surgically under general anesthesia, perioperative serum albumin
levels were examined in a large number of cases in a multicenter
study. However, although, in multivariate analysis, POMs was
associated with changes in perioperative serum albumin levels
significantly, in a univariate analysis, POMs was not related to
perioperative changes in serum albumin levels. This might be
related to low intervention rate of POMs and variety of
intervention rates at each institute. The differences of operation
time, amount of blood loss, and risk of general anesthesia might
also effect on results with low intervention rate of POMs.
In the present study, POMs appeared to exert positive effects
on perioperative serum albumin levels. In a previous study, the
number of decayed teeth was reported to be a significant factor
for lower albumin levels,[33] and mean clinical attachment loss
was also identified as a significant factor for lower albumin levels
Table 3
Final results of adjusted multivariate analysis of the effects of POMs on perioperative change of serum albumin level in all subjects.
Variables Estimate 95% CI Standard ß P value (Prob>jtj) Variance Inflation Factor
Gender (Female vs Male) 0.038 0.029 – 0.064 0.047 <.0001 1.018
Age (yr) 0.009 0.008 – 0.311 0.009 <.0001 1.200
Performance status 0.022 0.013 – 0.037 0.031 <.0001 1.064
ASA classification
∗ 0.066 0.052 – 0.077 0.080 <.0001 1.254
Serum albumin level at admission (g/dL) 0.673 0.657 – 0.669 0.689 <.0001 1.153
Operation time (minutes) 0.00015 0.000 – 0.059 0.000 <.0001 1.100
Blood loss (mL) 0.00001 0.000 – 0.027 0.000 0.0005 1.102
Intervention of POMs (Yes vs No) 0.022 0.033 – 0.033 0.012 <.0001 1.057
95% CI = 95% confidence interval, POMs = perioperative oral managements.
∗
The American Society of Anesthesiologists (ASA) physical status classification.
Table 4
Japanese literature review of the effects of the POMs.
Author (Year) Cancer site Number of Patients Effects of the POMs
Kataoka T, et al (2008)[21] Oral cavity 112 Reduction of prevalence of postoperative pneumonia
Uejima S, et al (2009)[22] Esophagus 51 Reduction of the number of bacterium and bacterial species detected with the endotracheal
bacteriological examination and shortening of postoperative SIRS period
Akutsu Y, et al (2010)[4] Esophagus 86 Reduction of prevalence of postoperative pneumonia
Hiramatsu T, et al (2014)[5] Esophagus 240 Reduction of prevalence of postoperative pneumonia
Tozawa S, etal (2015)[23] Digestive system 464 Shortening of postoperative hospitalization days and postoperative fasting period (especially in
stomach, small intestine, and large bowel)
Uruno, et al (2015)[24] Oral cavity 100 Shortening of postoperative hospitalization days, antibiotics administration period and postoperative
fasting period
Yamamura Y, et al (2016)[25] Lung 27 Reduction of prevalence of postoperative pneumonia and fever of ≥38°C, and shortening of
postoperative hospitalization days
Aizawa H, et al (2016)[26] Liver 80 Shortening of postoperative hospitalization days, antibiotics administration period and postoperative
fasting period
Soutome S, et al (2016)[27] Esophagus 383 Reduction of prevalence of postoperative pneumonia and intervention of POMs as risk factor for
postoperative pneumonia
Nishino T, et al. (2017)[28] Lung 264 Reduction of prevalence of postoperative pneumonia, Shortening of postoperative hospitalization
days, and lower postoperative CRP level
Soutome, et al (2017)[3] Esophagus 539 Reduction of prevalence of postoperative pneumonia and intervention of POMs as risk factor for
postoperative pneumonia
Kajihara R, et al. (2018)[29] Lung 480 Reduction of prevalence of postoperative pneumonia and intervention of POMs as risk factor for
postoperative pneumonia
Iwata E, et al. (2019)[6] Lung 721 Reduction of prevalence of postoperative pneumonia and intervention of POMs as risk factor for
postoperative pneumonia
Nobuhara H, et al. (2019)[30] Large bowel 698 Reduction of prevalence of SSI, shortening of postoperative hospitalization days, and intervention of
POMs as risk factor for postoperative pneumonia
CRP = C-reactive protein, POMs = perioperative oral managements, SIRS = systemic inflammatory response syndrome, SSI = surgical site infection.
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in the elderly.[34] Furthermore, a close relationship has been
reported between periodontitis and lower serum albumin
levels.[34–37] Periodontal treatment had a positive influence on
masticatory performance after conservative treatment.[38] Addi-
tionally, tooth loss may be a predictor for low energy and protein
intake as well as serum albumin levels.[39] On the other hand,
since serum albumin levels have been reported to significantly
increase among individuals using partial dentures,[40] prostho-
dontic treatments may be of clinical significance for improving
serum albumin levels. Therefore, the present results suggested
that POMs, including oral care, the removal of chronic dental
infections, and prosthodontic treatments, exerts positive effects
on perioperative serum albumin levels by inhibiting decreases in
early postoperative serum albumin levels in patients treated
surgically under general anesthesia.
The strength of the present study is that it is the first to clarify
the positive efficacy of POMs on perioperative serum albumin
levels in patients treated surgically under general anesthesia based
on a large number of cases. The limitation of the present study is
the differences observed in POMs criteria and treatment
protocols at each institute because of its retrospective nature.
Additionally, the intervention rate of POMs was low at 24.3% in
the present study. The reason for the low intervention rate of
POMs was probably due to the lack of coordination between
doctors and dentists, the treatment schedule, and patient
awareness of significance of POMs. However, difficulties are
associated with ethically conducting a prospective randomized
control study to evaluate the efficacy of POM because POMs has
been covered by the Japanese national health insurance system
since 2012, andmost Japanese patients now receive POMs before
cancer treatments. The protocol and intention of dental
interventions for patients remain controversial. The establish-
ment of guidelines for POMs in patients scheduled for surgery is
needed for the standardization of dental interventions. Addition-
ally, although periodontal conditions might affect on periopera-
tive serum albumin levels, effects of periodontal conditions were
uncertain, due to low intervention rate of POMs and large
population based study.
In conclusion, the intervention ratio of POMwas 24.3%. In the
multivariate analysis, perioperative serum albumin levels posi-
tively correlated with POMs. Therefore, the POMs may prevent
reductions in postoperative serum albumin levels and contribute
to patients treated with surgery under general anesthesia. The
POMs may play a possible role in reducing the side effects of
preoperative malnutrition.
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